Clinical Trials · NCT01769781
Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Centre for Endocrinology and Reproductive Medicine, Italy
- Enrollment
- 70
- Start date
- Jan 2013
- Locations
- 1 site, Italy
- Primary endpoint
- disease free time